Katalin Nógrádi

Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors

Éva Ágai-Csongor, György Domány, Katalin Nógrádi et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 89 citations · Full text

Medicinal Chemistry, Dopamine D3/d2 Receptors, Psychoactive Drug +8

Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications

János Galambos, Attila Bielik, Mikhail Krasavin et al. · Journal of Medicinal Chemistry · 2017 · 29 citations · Full text

Psychiatric Indications, High Throughput, Psychopharmacology +20

Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile

Éva Ágai-Csongor, Katalin Nógrádi, János Galambos et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 21 citations · Full text

Psychiatry, Medicine, Eps Profile +11

Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists

János Galambos, Gábor Wágner, Katalin Nógrádi et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 21 citations · Full text

Molecular Pharmacology, Biochemistry, Functional Selectivity +6

4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate

János Galambos, György Domány, Katalin Nógrádi et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 21 citations · Full text

Negative Allosteric Modulators, Signal Transduction, G Protein-coupled Receptor +9